Assignee
MEDIVATION PROSTATE THERAPEUTICS LLC
US·5 granted patents·6 pending applications·10 citations·filing 2015–2025
Top patents by PatentIndex Score
11 records- 0181US10196693B2Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancerMEDIVATION PROSTATE THERAPEUTICS LLC·Filed 2015·Granted Feb 5, 2019·6 cites·61 claims
- 0278US10111861B2Treatment of breast cancerMEDIVATION PROSTATE THERAPEUTICS LLC·Filed 2016·Granted Oct 30, 2018·2 cites·13 claims
- 0374US11186876B2Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancerMEDIVATION PROSTATE THERAPEUTICS LLC·Filed 2018·Granted Nov 30, 2021·2 cites·37 claims
- 0468US11952634B2Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancerMEDIVATION PROSTATE THERAPEUTICS LLC·Filed 2021·Granted Apr 9, 2024·0 cites·42 claims
- 0566US12161628B2Combination therapyMEDIVATION PROSTATE THERAPEUTICS LLC·Filed 2022·Granted Dec 10, 2024·0 cites·6 claims
- 0664US2019209476A1Formulations of enzalutamideMEDIVATION PROSTATE THERAPEUTICS LLC·Filed 2018·Application pending·0 cites
- 0762US2021069154A1Treatment of Breast CancerMEDIVATION PROSTATE THERAPEUTICS LLC·Filed 2020·Application pending·0 cites
- 0858US2026041676A1Combination TherapyMEDIVATION PROSTATE THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
- 0957US2019262315A1Treatment of Breast CancerMEDIVATION PROSTATE THERAPEUTICS LLC·Filed 2018·Application pending·0 cites
- 1052US2021069166A1Combination TherapyMEDIVATION PROSTATE THERAPEUTICS LLC·Filed 2020·Application pending·0 cites
- 1141US2018235935A1Treatment of Cancer with Enzalutamide and a CYP3A4 InhibitorMEDIVATION PROSTATE THERAPEUTICS LLC·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →